Helicobacter pylori eradication for gastric cancer prevention

Accession number;07A0177221
Title;Helicobacter pylori eradication for gastric cancer prevention
Author; CHEUNG TING KIN (Univ. Hong Kong, Hkg) XIA HARRY H.X. (Univ. Hong Kong, Hkg) WONG BENJAMIN C.Y. (Univ. Hong Kong, Hkg)
Journal Title;J Gastroenterol
Journal Code:Z0748A
ISSN:0944-1174
VOL.42;NO.Supplement 17;PAGE.10-15(2007)
Figure&Table&Reference;
Pub. Country;Japan
Language;English
Abstract;Gastric cancer is the second most common fatal malignancy in the world. Its incidence is high in East Asia. Helicobacter pylori infection is an important factor in the pathogenesis of gastric cancer. Epidemiological studies have established a strong causal relationship between H. pylori infection and gastric cancer. H. pylori eradication is therefore likely to be one of the most promising approaches to gastric cancer prevention. Animal studies have shown that eradication of H. pylori infection, especially at the early stage, is effective in preventing H. pylori-related gastric carcinogenesis. However, the available data from human studies show that H. pylori eradication does not completely prevent gastric cancer and that it might be useful only in patients without atrophic gastritis or intestinal metaplasia at baseline. Longer follow-up and additional studies are needed to clarify this issue. (author abst.)